Laryngeal cancer (LC) remains a challenging disease to treat. The majority of LCs
diagnosed worldwide are squamous cell carcinomas (SCC), and current treatment …

Answer questions and earn CME/CNE Laryngeal cancer remains one of the most common
tumors of the respiratory tract. Fortunately, significant advancements have been made over …

Squamous cell carcinoma of the larynx continues to be the commonest head and neck
cancer in many Western countries. The larynx plays a key role for many essential functions …

Importance of the field: Laryngeal cancer has been the model of curative-intent organ-
preserving therapies in clinical oncology. Although the optimal care of patients with …

Historically, patients with advanced laryngeal cancer have been treated with radical surgery
and adjuvant radiation therapy. Intensive surgical research has allowed surgeons to deal …

(1) Background: Non-squamous cell laryngeal carcinoma includes endothelial tumors, such
as minor salivary gland tumors, lymphoepithelial tumors, neuroendocrine tumors, soft and …

Treatment of larynx cancer has changed dramatically over the past several years. Novel
modalities of treatment have been introduced as organ preservation has been developed. In …

The treatment of advanced laryngeal cancer has undergone a paradigm shift in recent
years, with an increase in chemoradiation for organ preservation and a decrease in primary …

The current treatment paradigm for patients with advanced laryngeal squamous cell
carcinoma continues to evolve. The authors assembled a panel of experts from the fields of …

Nowadays clinics can offer patients a variety of different therapy options when laryngeal
squamous cell carcinoma is diagnosed histologically. Depending on a variety of different …